The Pharmacy Times® Cardiovascular Health resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.
What can we help you find?
A recent study showed that long-term exposure to fine particulate outdoor air pollution is a key contributor to cardiovascular disease and death throughout the world, regardless of the income bracket of the various countries.
Collaboration between pharmacists and general practice teams improves patient care and increases savings.
A new heart valve combines the biocompatibility of a biological valve with the robustness of a mechanical one.
COVID-19 attacks the cardiovascular system and may exasperate preexisting heart conditions.
Current research has already found that CVD is among the most common pre-existing conditions among people who die from COVID-19.
Cytomegalovirus Disease Prevention in High-Risk Liver Transplant Patients: Preemptive Therapy or Prophylaxis?
Organ transplants from seropositive donors carry a high risk of infection from the transplanted organ.
The paper is an update to previous guidelines released by ACSM and the American Heart Association in 1998.
Data from a new analysis reinforces concerns surrounding the detrimental impact the novel osteoporotic therapy romosozumab can have on cardiovascular health.
Research shows that the over-prescribing of opioids for short term pain management is a widespread issue in the United States.
individuals with four or more depressive symptoms had a 20% increase in cardiovascular events and death.
Current treatment guidelines do not recommend the use of either drug in hospitalized patients with COVID-19 outside of clinical trials.
Reducing salt intake to a healthier level appears to be beneficial for the gut microbiome and blood pressure, especially in females with untreated hypertension, according to researchers at the Medical College of Georgia at Augusta University.